Effect of protease treatment on the sensitivity of tumor cells to antibody-GPC killing
- 1 May 1978
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 10 (1), 84-94
- https://doi.org/10.1016/0090-1229(78)90012-0
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- DEMONSTRATION OF A COMPLEMENT INACTIVATOR ON CULTURED CELLS FROM HUMAN MALIGNANT BRAIN TUMOURSActa Neurologica Scandinavica, 2009
- Quantitation of antibody-complement mediated lysis of tumor cellsJournal of Immunological Methods, 1977
- Complement inhibitor(s) released from leukocytesCellular Immunology, 1976
- VARIATION IN SUSCEPTIBILITY OF A HUMAN LYMPHOID CELL LINE TO IMMUNE LYSIS DURING THE CELL CYCLEThe Journal of Experimental Medicine, 1974
- Immunochemical Detection of Tumor-Specific and Embryonic Antigens of Diethylnitrosamine-Induced Guinea Pig Tumors2JNCI Journal of the National Cancer Institute, 1973
- Lysis of Tumor Cells by Antibody and Complement. I. Lack of Correlation Between Antigen Content and Lytic SusceptibilityJNCI Journal of the National Cancer Institute, 1973
- Fusion of Frog and Tadpole ErythrocytesNature, 1972
- Inhibition of complement by a substance isolated from human erythrocytes—II: Studies on the site and mechanism of actionImmunochemistry, 1969
- Inhibition of complement by a substance isolated from human erythrocytes — I: Extraction from human erythrocyte stromataImmunochemistry, 1969
- Immunogenicity of L 1210 Murine Leukaemia Cells after Treatment with NeuraminidaseNature, 1968